These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5680145)

  • 1. [Drug therapy in Hodgkin's disease].
    Stenfert Kroese WF
    Ned Tijdschr Geneeskd; 1968 Sep; 112(38):1691-6. PubMed ID: 5680145
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the bone marrow granulocyte reserve in patients with Hodgkin's disease during antiblastic polychemo- and radiation therapy].
    Santagati G; Nicolini E; Zibetti G; Paladini G
    Minerva Med; 1978 May; 69(25):1739-43. PubMed ID: 662176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Letter: Bone Marrow localization of Hodgkin's disease. Combination drug therapy].
    Fière D; Bryon PA
    Nouv Presse Med; 1975 Mar; 4(9):671. PubMed ID: 1129135
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Hodgkin's disease. Five years' experience of a combined haemic-lymphatic clinic.
    Ewing DP; Rozenberg MC; Freedman A; Grace CS; Lam-Po-Tang PR
    Med J Aust; 1974 Jul; 2(4):128-32. PubMed ID: 4419384
    [No Abstract]   [Full Text] [Related]  

  • 5. The therapy of Hodgkin's disease--1978: a combined modality approach.
    Prosnitz LR; Montalvo RL
    Prog Clin Cancer; 1978; 7():97-112. PubMed ID: 360282
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of advanced Hodgkin's disease at Memorial Hospital.
    Straus DJ; Young CW; Lee BJ; Koziner B; Clarkson BD; Nisce LZ
    Clin Bull; 1980; 10(4):138-43. PubMed ID: 7214703
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bone-marrow hematopoiesis in the irradiated area with combined chemo- and radiation therapy (author's transl)].
    Baisogolov GD; Isaev IG
    Radiobiol Radiother (Berl); 1981; 22(1):44-8. PubMed ID: 7232707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern therapy of Hodgkin's disease and of acute leukemias].
    Bernard J
    Clin Ter; 1967 Jun; 41(6):507-13. PubMed ID: 5604096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current therapy of Hodgkin's disease].
    Teillet F
    Minerva Med; 1968 Dec; 59(100):5584-97. PubMed ID: 5707467
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic criteria in Hodgkin's lymphoma. Osseous localizations].
    Bottoni P; Nicolato A; Franchini P; Rogledi D; Orlandi C; Pettene-Bottoni A; Bobba L
    Minerva Med; 1979 Apr; 70(18):1279-88. PubMed ID: 109790
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present-day treatment of Hodgkin's disease].
    Debray JM
    Therapie; 1977; 32(3):249-58. PubMed ID: 929496
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications and therapeutic combinations in Hodgkin's disease].
    Malamos B
    Rev Med Moyen Orient; 1967; 24(2):112-3. PubMed ID: 5248413
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intensive therapy of Hodgkin's disease].
    Bonadonna G
    Haematologica; 1973; 53(1):27-50. PubMed ID: 4198539
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's disease.
    Cooper I
    Med J Aust; 1977 Dec; 2(25):817-8. PubMed ID: 613193
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy as a primary treatment of Hodgkin's disease.
    Miller DG
    Cancer Res; 1966 Jun; 26(6):1303-7. PubMed ID: 5947355
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of Hodgkin's disease.
    Falkson G; Falkson HC
    S Afr J Surg; 1966; 4(3):123-6. PubMed ID: 5981370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Life expectancy in Hodgkin's disease].
    Bernadou A; Bousser J
    Rev Prat; 1974 Oct; 24(45):3999-4002. PubMed ID: 4445769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extended irradiation in Hodgkin's disease. Early reactions].
    Tubiana M; Rambert P; Laugier A; Lalanne CM
    Nouv Rev Fr Hematol; 1966; 6(1):164-74. PubMed ID: 4222299
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of Hodgkin's disease].
    Jacquillat C; Weil M; Auclerc G
    Therapeutique; 1973 Apr; 49(4):287-91. PubMed ID: 4775223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.